Related Experiment Video
Updated: Aug 13, 2026
Minimally Invasive Establishment of Murine Orthotopic Bladder Xenografts
Published on: February 11, 2014
Minimally invasive surgery does not improve the outcome in a model of retroperitoneal murine neuroblastoma
T Iwanaka1, G Arya, M M Ziegler
1Division of Pediatric Surgery, Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Abstract:
Minimally invasive surgery (MIS) for cancer patients has become widely accepted in general surgery, however, it has not completely replaced the standard open operative procedures in pediatric oncology. The aim of this study was to evaluate the host relationship following MIS in a murine model of retroperitoneal neuroblastoma (NB) Immature, 5- to 7-week-old male A/J mice weighing 18-23 g were inoculated with either C1300 or TBJ NB in the left retroperitoneal space. At 4 days (early stage) or 11 days (late stage) following tumor inoculation, the animals underwent a laparotomy or pneumoperitoneum with carbon dioxide under general inhalational anesthesia. Animal survival, tumor growth, and postoperative changes in body weight were observed. In the model of subcutaneous TBJ NB, distant metastases following the laparotomy or MIS technique were also evaluated. Each surgical group had a sample size > or = 12, and data were statistically analyzed by ANOVA and the chi-square test where appropriate. P < 0.05 was considered to be significant. There were no significant differences in animal survival, tumor growth, or distant metastases among surgical groups in any combination of type and stage of tumor. The only salutary influence of MIS was seen in a model of early-stage NB, where the decrease in body weight on postoperative day 7 was preserved when compared to post-laparotomy weight loss. We conclude that when compared to conventional laparotomy, the MIS access technique does not influence the outcome in a model of retroperitoneal murine NB.
Insights
Minimally invasive surgery (MIS) did not affect survival or tumor growth in a murine neuroblastoma model. However, MIS preserved body weight in early-stage disease compared to laparotomy.
Area of Science:
- Pediatric Oncology
- Surgical Innovation
- Oncology Research
Background:
- Minimally invasive surgery (MIS) is common in general surgery but less so in pediatric oncology.
- The efficacy of MIS versus open surgery in pediatric neuroblastoma (NB) requires further investigation.
Purpose of the Study:
- To evaluate the host response to MIS in a murine model of retroperitoneal neuroblastoma.
- To compare outcomes of MIS and laparotomy in terms of survival, tumor growth, and metastasis.
Main Methods:
- A/J mice were inoculated with C1300 or TBJ neuroblastoma (NB) retroperitoneally.
- Animals underwent laparotomy or MIS (pneumoperitoneum with CO2) at early (4 days) or late (11 days) stages.
- Survival, tumor growth, body weight changes, and distant metastases were assessed.
Main Results:
- No significant differences in survival, tumor growth, or distant metastases were observed between MIS and laparotomy groups.
- MIS showed a benefit in preserving body weight on postoperative day 7 in early-stage NB compared to laparotomy.
Conclusions:
- The MIS access technique does not appear to influence the overall outcome (survival, tumor growth, metastasis) in this retroperitoneal murine NB model compared to conventional laparotomy.
- MIS may offer a slight advantage in mitigating postoperative weight loss in early-stage disease.
